When CFZ is combined with obatoclax, a pan-BH3 mimetic that inhibits Mcl-1, enhanced apoptosis is observed in diffuse large B-cell lymphoma cell lines [48]. The gene discussed is MCL1; the disease is diffuse large B-cell lymphoma.